The Drug Resistant TB Challenge of India

Reference news Recently, a study published in The Lancet indicates that India’s TB crisis will become very grave by 2040 when one in 10 cases could be drug-resistant — both: multidrug-resistant TB (or MDR-TB, resistant to more than one of the first-line drugs); and extensively drug-resistant TB (or XDR-TB, also resistant to fluoroquinolones and at […]

Full access to this article is available to Members only. To read this article and all other premium articles, you need to get membership, (plans starting at just 150).
Please log in if you are already a member.